Free Trial

Delcath Systems (DCTH) Competitors

Delcath Systems logo
$15.96 -0.25 (-1.54%)
Closing price 06/11/2025 04:00 PM Eastern
Extended Trading
$16.27 +0.31 (+1.94%)
As of 06/11/2025 06:43 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

DCTH vs. WRBY, NVCR, LMAT, CNMD, ENOV, EYE, LQDA, TNDM, CDRE, and AORT

Should you be buying Delcath Systems stock or one of its competitors? The main competitors of Delcath Systems include Warby Parker (WRBY), NovoCure (NVCR), LeMaitre Vascular (LMAT), CONMED (CNMD), Enovis (ENOV), National Vision (EYE), Liquidia (LQDA), Tandem Diabetes Care (TNDM), Cadre (CDRE), and Artivion (AORT). These companies are all part of the "medical equipment" industry.

Delcath Systems vs. Its Competitors

Delcath Systems (NASDAQ:DCTH) and Warby Parker (NYSE:WRBY) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their media sentiment, risk, earnings, profitability, institutional ownership, dividends, analyst recommendations, valuation and community ranking.

Warby Parker has a net margin of -4.39% compared to Delcath Systems' net margin of -150.70%. Warby Parker's return on equity of -8.26% beat Delcath Systems' return on equity.

Company Net Margins Return on Equity Return on Assets
Delcath Systems-150.70% -338.16% -104.02%
Warby Parker -4.39%-8.26%-4.37%

In the previous week, Warby Parker had 4 more articles in the media than Delcath Systems. MarketBeat recorded 5 mentions for Warby Parker and 1 mentions for Delcath Systems. Delcath Systems' average media sentiment score of 1.87 beat Warby Parker's score of 1.19 indicating that Delcath Systems is being referred to more favorably in the media.

Company Overall Sentiment
Delcath Systems Very Positive
Warby Parker Positive

Delcath Systems has higher earnings, but lower revenue than Warby Parker. Warby Parker is trading at a lower price-to-earnings ratio than Delcath Systems, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Delcath Systems$53.85M10.32-$47.68M-$0.50-31.92
Warby Parker$795.09M2.97-$63.20M-$0.12-188.12

Delcath Systems presently has a consensus target price of $24.00, suggesting a potential upside of 50.38%. Warby Parker has a consensus target price of $22.88, suggesting a potential upside of 1.33%. Given Delcath Systems' stronger consensus rating and higher probable upside, analysts clearly believe Delcath Systems is more favorable than Warby Parker.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Delcath Systems
0 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
3.00
Warby Parker
0 Sell rating(s)
7 Hold rating(s)
11 Buy rating(s)
0 Strong Buy rating(s)
2.61

61.1% of Delcath Systems shares are held by institutional investors. Comparatively, 93.2% of Warby Parker shares are held by institutional investors. 17.4% of Delcath Systems shares are held by insiders. Comparatively, 18.2% of Warby Parker shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Warby Parker received 19 more outperform votes than Delcath Systems when rated by MarketBeat users. Likewise, 46.61% of users gave Warby Parker an outperform vote while only 29.27% of users gave Delcath Systems an outperform vote.

CompanyUnderperformOutperform
Delcath SystemsOutperform Votes
36
29.27%
Underperform Votes
87
70.73%
Warby ParkerOutperform Votes
55
46.61%
Underperform Votes
63
53.39%

Delcath Systems has a beta of 0.95, indicating that its share price is 5% less volatile than the S&P 500. Comparatively, Warby Parker has a beta of 2.1, indicating that its share price is 110% more volatile than the S&P 500.

Summary

Warby Parker beats Delcath Systems on 12 of the 18 factors compared between the two stocks.

Get Delcath Systems News Delivered to You Automatically

Sign up to receive the latest news and ratings for DCTH and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding DCTH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

DCTH vs. The Competition

MetricDelcath SystemsSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$555.82M$4.41B$5.57B$8.61B
Dividend YieldN/A42.67%5.28%4.18%
P/E Ratio-11.8228.4427.1720.06
Price / Sales10.3271.85409.72157.10
Price / CashN/A51.0838.2534.64
Price / Book22.175.917.064.70
Net Income-$47.68M$67.63M$3.23B$247.88M
7 Day Performance-5.39%2.35%2.89%2.66%
1 Month Performance10.45%17.24%9.06%6.40%
1 Year Performance122.59%19.59%31.40%14.07%

Delcath Systems Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
DCTH
Delcath Systems
3.5612 of 5 stars
$15.96
-1.5%
$24.00
+50.4%
+132.0%$555.82M$53.85M-11.8260
WRBY
Warby Parker
2.0805 of 5 stars
$21.49
+1.5%
$22.88
+6.4%
+35.5%$2.25B$795.09M-79.603,030Positive News
NVCR
NovoCure
4.0599 of 5 stars
$17.04
-10.8%
$32.83
+92.7%
-18.9%$1.90B$621.71M-12.171,320High Trading Volume
LMAT
LeMaitre Vascular
2.9261 of 5 stars
$80.40
-2.2%
$97.83
+21.7%
+7.1%$1.82B$226.26M43.93490Positive News
CNMD
CONMED
4.0365 of 5 stars
$55.32
-2.5%
$62.20
+12.4%
-23.3%$1.71B$1.32B13.054,100
ENOV
Enovis
2.7239 of 5 stars
$29.62
-5.4%
$58.00
+95.8%
-25.5%$1.69B$2.15B-13.536,800High Trading Volume
EYE
National Vision
3.2671 of 5 stars
$21.19
+7.0%
$17.75
-16.2%
+49.6%$1.68B$1.85B-105.9414,000Positive News
High Trading Volume
LQDA
Liquidia
3.7554 of 5 stars
$16.87
+13.1%
$26.67
+58.1%
+2.3%$1.44B$14.14M-10.3550Trending News
Analyst Forecast
Options Volume
High Trading Volume
TNDM
Tandem Diabetes Care
4.0385 of 5 stars
$20.22
+2.0%
$35.86
+77.3%
-55.5%$1.35B$982.95M-10.482,600Positive News
CDRE
Cadre
2.9938 of 5 stars
$32.97
+0.6%
$37.00
+12.2%
+7.1%$1.34B$559.81M39.722,240Positive News
AORT
Artivion
2.5233 of 5 stars
$28.74
-2.8%
$31.40
+9.3%
+23.6%$1.23B$390.08M-1,437.001,300Short Interest ↓

Related Companies and Tools


This page (NASDAQ:DCTH) was last updated on 6/12/2025 by MarketBeat.com Staff
From Our Partners